These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15764199)

  • 1. Piperacillin-resistant Escherichia coli bacteraemia: relation to empiric therapy and clinical outcome.
    Andersen NF; Møller J; Peterslund NA
    Scand J Infect Dis; 2005; 37(2):90-5. PubMed ID: 15764199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
    Peralta G; Sánchez MB; Garrido JC; De Benito I; Cano ME; Martínez-Martínez L; Roiz MP
    J Antimicrob Chemother; 2007 Oct; 60(4):855-63. PubMed ID: 17644532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome.
    Ortega M; Marco F; Soriano A; Almela M; Martínez JA; Muñoz A; Mensa J
    J Antimicrob Chemother; 2009 Mar; 63(3):568-74. PubMed ID: 19126669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region.
    Laupland KB; Gregson DB; Church DL; Ross T; Pitout JD
    Clin Microbiol Infect; 2008 Nov; 14(11):1041-7. PubMed ID: 19040476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of healthcare-associated infections in community-onset Escherichia coli bacteraemia.
    Cheong HS; Kang CI; Kwon KT; Heo ST; Wi YM; Kim ES; Lee JS; Ko KS; Chung DR; Lee NY; Song JH; Peck KR
    J Antimicrob Chemother; 2007 Dec; 60(6):1355-60. PubMed ID: 17923453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical consequences of increased ciprofloxacin and gentamicin resistance in patients with Escherichia coli bacteraemia in the Netherlands.
    Cranendonk DR; van der Valk M; Langenberg ML; van der Meer JT
    Scand J Infect Dis; 2012 May; 44(5):363-8. PubMed ID: 22200089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiological spectrum and susceptibility patterns of pathogens causing bacteraemia in paediatric febrile neutropenic oncology patients: comparison between two consecutive time periods with use of different antibiotic treatment protocols.
    Greenberg D; Moser A; Yagupsky P; Peled N; Hofman Y; Kapelushnik J; Leibovitz E
    Int J Antimicrob Agents; 2005 Jun; 25(6):469-73. PubMed ID: 15890499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comment on: Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
    Blot S; Vandijck D; Vandewoude K; Depuydt P; Vogelaers D; Peleman R
    J Antimicrob Chemother; 2007 Dec; 60(6):1402. PubMed ID: 17913718
    [No Abstract]   [Full Text] [Related]  

  • 9. Time-to-positivity in patients with Escherichia coli bacteraemia.
    Peralta G; Roiz MP; Sánchez MB; Garrido JC; Ceballos B; Rodríguez-Lera MJ; Mateos F; De Benito I
    Clin Microbiol Infect; 2007 Nov; 13(11):1077-82. PubMed ID: 17727685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies.
    Trecarichi EM; Tumbarello M; Spanu T; Caira M; Fianchi L; Chiusolo P; Fadda G; Leone G; Cauda R; Pagano L
    J Infect; 2009 Apr; 58(4):299-307. PubMed ID: 19272650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
    Cordery RJ; Roberts CH; Cooper SJ; Bellinghan G; Shetty N
    J Hosp Infect; 2008 Feb; 68(2):108-15. PubMed ID: 18063198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Escherichia coli a forgotten pathogen in septicemia].
    Sledzińska A; Samet A; Bronk M; Rybak B; Kur J; Krawczyk B; Nowicki B
    Przegl Epidemiol; 2006; 60(1):27-34. PubMed ID: 16758735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciprofloxacin-resistant Escherichia coli from bacteraemias in England; increasingly prevalent and mostly from men.
    Livermore DM; Nichols T; Lamagni TL; Potz N; Reynolds R; Duckworth G
    J Antimicrob Chemother; 2003 Dec; 52(6):1040-2. PubMed ID: 14585850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity and smoking are factors associated with poor prognosis in patients with bacteraemia.
    Huttunen R; Laine J; Lumio J; Vuento R; Syrjänen J
    BMC Infect Dis; 2007 Mar; 7():13. PubMed ID: 17349033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug-resistant Escherichia coli bacteremia in cancer patients.
    Vigil KJ; Adachi JA; Aboufaycal H; Hachem RY; Reitzel RA; Jiang Y; Tarrand JJ; Chemaly RF; Bodey GP; Rolston KV; Raad I
    Am J Infect Control; 2009 Nov; 37(9):741-5. PubMed ID: 19487050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and clinical outcome of enterococcal bacteraemia in an acute care hospital.
    Poh CH; Oh HM; Tan AL
    J Infect; 2006 May; 52(5):383-6. PubMed ID: 16203039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infections due to Escherichia coli producing extended-spectrum beta-lactamase among hospitalised patients: factors influencing mortality.
    Peña C; Gudiol C; Calatayud L; Tubau F; Domínguez MA; Pujol M; Ariza J; Gudiol F
    J Hosp Infect; 2008 Feb; 68(2):116-22. PubMed ID: 18226420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A matched prospective cohort study on Staphylococcus aureus and Escherichia coli bloodstream infections: extended perspectives beyond resistance.
    Berger J; Diab-Elschahawi M; Blacky A; Pernicka E; Spertini V; Assadian O; Koller W; Aichberger KJ
    Am J Infect Control; 2010 Dec; 38(10):839-45. PubMed ID: 20650546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of low blood glucose at the presentation of E. coli bacteremia.
    Alamgir S; Volkova NB; Peterson MW
    Am J Med; 2006 Nov; 119(11):952-7. PubMed ID: 17071163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of bacteraemia and mortality in patients with haematological malignancies.
    Nørgaard M; Larsson H; Pedersen G; Schønheyder HC; Sørensen HT
    Clin Microbiol Infect; 2006 Mar; 12(3):217-23. PubMed ID: 16451407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.